199 related articles for article (PubMed ID: 358397)
1. Antimalarials in the management of discoid and systemic lupus erythematosus.
Dubois EL
Semin Arthritis Rheum; 1978 Aug; 8(1):33-51. PubMed ID: 358397
[No Abstract] [Full Text] [Related]
2. Discoid lupus erythematosus.
Brown RK
Arch Dermatol; 1972 May; 105(5):768-70. PubMed ID: 4537259
[No Abstract] [Full Text] [Related]
3. [Combination of antimalarial drugs mepacrine and chloroquine in therapy refractory cutaneous lupus erythematosus].
von Schmiedeberg S; Rönnau AC; Schuppe HC; Specker C; Ruzicka T; Lehmann P
Hautarzt; 2000 Feb; 51(2):82-5. PubMed ID: 10743578
[TBL] [Abstract][Full Text] [Related]
4. The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus.
Feldmann R; Salomon D; Saurat JH
Dermatology; 1994; 189(4):425-7. PubMed ID: 7873836
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial therapy in SLE.
Lanham JG; Hughes GR
Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
[No Abstract] [Full Text] [Related]
6. Is chloroquine neuromyotoxicity in a patient with refractory discoid lupus erythematosus potentiated by concomitant use of mepacrine?
Winn RT; Miller JAL; Meggitt SJ
Clin Exp Dermatol; 2018 Dec; 43(8):927-928. PubMed ID: 29808483
[No Abstract] [Full Text] [Related]
7. Chloroquine-induced myopathy.
Posada C; García-Cruz A; García-Doval I; Millán BS; Teijeira S
Lupus; 2011 Jun; 20(7):773-4. PubMed ID: 21300683
[No Abstract] [Full Text] [Related]
8. [Antimalarial's retinopaty remains a current threat].
Chiffoleau A; Guillet A; Zanlonghi X; Jolliet P
Presse Med; 2009 Apr; 38(4):662-3. PubMed ID: 19135848
[No Abstract] [Full Text] [Related]
9. [Complications with synthetic antimalarials].
Huriez C; Desmons F; Gautier G; Dhellemmes
Lille Med; 1969 Oct; 14(8):851-64. PubMed ID: 4251585
[No Abstract] [Full Text] [Related]
10. Antimalarials and ophthalmologic safety.
Olansky AJ
J Am Acad Dermatol; 1982 Jan; 6(1):19-23. PubMed ID: 7045172
[TBL] [Abstract][Full Text] [Related]
11. [Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series].
González-Sixto B; García-Doval I; Oliveira R; Posada C; García-Cruz MA; Cruces M
Actas Dermosifiliogr; 2010; 101(1):54-8. PubMed ID: 20109393
[TBL] [Abstract][Full Text] [Related]
12. Ocular toxicity of antimalarial drugs. Long-term follow-up.
Carr RE; Henkind P; Rothfield N; Siegel IM
Am J Ophthalmol; 1968 Oct; 66(4):738-44. PubMed ID: 5729592
[No Abstract] [Full Text] [Related]
13. PIGMENTATION FROM ANTIMALARIAL THERAPY. ITS POSSIBLE RELATIONSHIP TO THE OCULAR LESIONS.
TUFFANELLI D; ABRAHAM RK; DUBOIS EI
Arch Dermatol; 1963 Oct; 88():419-26. PubMed ID: 14051353
[No Abstract] [Full Text] [Related]
14. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
Spinelli FR; Moscarelli E; Ceccarelli F; Miranda F; Perricone C; Truglia S; Garufi C; Massaro L; Morello F; Alessandri C; Valesini G; Conti F
Lupus; 2018 Sep; 27(10):1616-1623. PubMed ID: 29954281
[TBL] [Abstract][Full Text] [Related]
15. Recent findings about antimalarials in cutaneous lupus erythematosus: What dermatologists should know.
Teboul A; Arnaud L; Chasset F
J Dermatol; 2024 Jul; 51(7):895-903. PubMed ID: 38482997
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine: consideration of maximum daily dose (3.5 mg/kg ideal body weight) prevents retinopathy.
Ochsendorf FR; Runne U
Dermatology; 1996; 192(4):382-3. PubMed ID: 8864383
[No Abstract] [Full Text] [Related]
17. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
[TBL] [Abstract][Full Text] [Related]
18. Pigmentation of the hard palate.
Lerman MA; Karimbux N; Guze KA; Woo SB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):8-12. PubMed ID: 18801675
[No Abstract] [Full Text] [Related]
19. [Treatment of discoid lupus erythematosus, polymorphous photodermatosis and rosacea with Triquin--a combination of 3 anti-malarials].
FREDRIKSSON T; LODIN A; ROSENGREN S
Sven Lakartidn; 1962 Oct; 59():2858-62. PubMed ID: 13959402
[No Abstract] [Full Text] [Related]
20. [CHRONIC DISCOID ERYTHEMATOSUS (REPORT ON 69 CASES OVER A PERIOD OF 6 YEARS FROM THE VIEWPOINT OF OPTIMUM THERAPY)].
BORC K
Cesk Dermatol; 1963 Aug; 38():293-7. PubMed ID: 14085999
[No Abstract] [Full Text] [Related]
[Next] [New Search]
